Publication

In the first half of 2024, Tapestry Networks engaged with payers, self-insured employers, clinicians, patient advocates, and industry representatives to consider how modifications to prior authorization processes might improve quality of care for inflammatory bowel disease (IBD). These discussions culminated in a virtual June 2024 multistakeholder meeting of the IBD Shared Value Initiative, where participants considered research initiatives and pilots to generate evidence for potentially measurable benefits of PA modification. This Summary of Themes provides a synthesis of views that arose during the meeting and in pre- and post-meeting discussions.